Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Stabilizing HIV-1 envelope glycoprotein trimers to induce neutralizing antibodies ; volume:15 ; number:1 ; day:12 ; month:9 ; year:2018 ; pages:1-11 ; date:12.2018
Retrovirology ; 15, Heft 1 (12.9.2018), 1-11, 12.2018
- Urheber
-
Torrents de la Peña, Alba
- Beteiligte Personen und Organisationen
-
Sanders, Rogier W.
SpringerLink (Online service)
- DOI
-
10.1186/s12977-018-0445-y
- URN
-
urn:nbn:de:101:1-2018102821515432938583
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Torrents de la Peña, Alba
- Sanders, Rogier W.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System
Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
Neutralizing activities of caprine antibodies towards conserved regions of the HCV envelope glycoprotein E2
Identification of broadly neutralizing antibody epitopes in the HIV-1 envelope glycoprotein using evolutionary models
HIV-1 envelope glycoprotein signatures that correlate with the development of cross-reactive neutralizing activity
Broader HIV-1 neutralizing antibody responses induced by envelope glycoprotein mutants based on the EIAV attenuated vaccine
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein
V5 region in the HIV-1 envelope glycoprotein determines viral sensitivity to the broadly neutralizing monoclonal antibody VRC01
Protective capacity of neutralizing and non-neutralizing antibodies against glycoprotein B of cytomegalovirus
Conformational Changes in the HIV/SIV Envelope Glycoprotein
Glycan shield of the ebolavirus envelope glycoprotein GP
HIV-1 envelope glycoprotein characteristics that correlate with the development of cross-reactive neutralizing activity in HIV-1 infected individuals
A Functional Henipavirus Envelope Glycoprotein Pseudotyped Lentivirus Assay System